Clinical Trial Update: Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and preliminary efficacy of AC0010 in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AC0010

Snippet

Sponsor: Hangzhou ACEA Pharmaceutical Research Co., Ltd. | Conditions: Carcinoma，Non-Small-Cell Lung | Phase 1 | Status: COMPLETED